Centaurus Financial’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-40,255
| Closed | -$36K | – | 951 |
|
|
2022
Q4 | $36K | Hold |
40,255
| – | – | ﹤0.01% | 825 |
|
|
2022
Q3 | $63K | Hold |
40,255
| – | – | 0.01% | 838 |
|
|
2022
Q2 | $81K | Hold |
40,255
| – | – | 0.01% | 811 |
|
|
2022
Q1 | $94K | Buy |
40,255
+2,700
| +7% | +$6.31K | 0.01% | 870 |
|
|
2021
Q4 | $175K | Buy |
37,555
+8,020
| +27% | +$37.4K | 0.01% | 714 |
|
|
2021
Q3 | $225K | Buy |
29,535
+4,100
| +16% | +$31.2K | 0.02% | 619 |
|
|
2021
Q2 | $246K | Hold |
25,435
| – | – | 0.02% | 620 |
|
|
2021
Q1 | $210K | Hold |
25,435
| – | – | 0.02% | 588 |
|
|
2020
Q4 | $174K | Hold |
25,435
| – | – | 0.02% | 589 |
|
|
2020
Q3 | $284K | Sell |
25,435
-2,840
| -10% | -$31.7K | 0.04% | 382 |
|
|
2020
Q2 | $178K | Buy |
28,275
+275
| +1% | +$1.73K | 0.03% | 456 |
|
|
2020
Q1 | $52K | Buy |
28,000
+5,000
| +22% | +$9.29K | 0.01% | 509 |
|
|
2019
Q4 | $78K | Buy |
23,000
+5,000
| +28% | +$17K | 0.01% | 619 |
|
|
2019
Q3 | $39K | Hold |
18,000
| – | – | 0.01% | 443 |
|
|
2019
Q2 | $48K | Buy |
18,000
+17,914
| +20,830% | +$47.8K | 0.01% | 589 |
|
|
2019
Q1 | $18K | Buy |
+86
| New | +$18K | 0.11% | 170 |
|
|
2018
Q3 | – | Sell |
-3,000
| Closed | -$22K | – | 2196 |
|
|
2018
Q2 | $22K | Buy |
+3,000
| New | +$22K | ﹤0.01% | 1241 |
|